Nanomedicines based on recombinant fusion proteins for targeting therapeutic siRNA oligonucleotides

Por Winkler, Johannes
Publicado em 2011

The shape of things to come: importance of design in nanotechnology for drug delivery

Por Liu, Yaling, Tan, Jifu, Thomas, Antony, Ou-Yang, Daniel, Muzykantov, Vladimir R
Publicado em 2012

Size matters: gold nanoparticles in targeted cancer drug delivery

Por Dreaden, Erik C, Austin, Lauren A, Mackey, Megan A, El-Sayed, Mostafa A
Publicado em 2012

Delivery of local therapeutics to the brain: working toward advancing treatment for malignant gliomas

Por Chaichana, Kaisorn L, Pinheiro, Leon, Brem, Henry
Publicado no Ther Deliv (2015)

Controlling subcellular delivery to optimize therapeutic effect

Por Mossalam, Mohanad, Dixon, Andrew S, Lim, Carol S
Publicado em 2010

Intracellular delivery of RNA-based therapeutics using aptamers

Por Thiel, Kristina W, Giangrande, Paloma H
Publicado em 2010

Novel lipoidal amine-based nanocarrier formulations for siRNA delivery

Por Zhou, Chenguang, Zhang, Yue, Lee, L James, Lee, Robert J
Publicado em 2012

Therapeutic nanomedicine for brain cancer

Por Tzeng, Stephany Y, Green, Jordan J
Publicado em 2013

Nanomicellar carriers for targeted delivery of anticancer agents

Por Zhang, Xiaolan, Huang, Yixian, Li, Song
Publicado em 2014

Non-invasive radiofrequency ablation of malignancies mediated by quantum dots, gold nanoparticles and carbon nanotubes

Por Glazer, Evan S, Curley, Steven A
Publicado em 2011

Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy

Por Spencer, Drew A, Young, Jacob S, Kanojia, Deepak, Kim, Julius W, Polster, Sean P, Murphy, Jason P, Lesniak, Maciej S
Publicado no Ther Deliv (2015)

Viral vectors and delivery strategies for CNS gene therapy

Por Gray, Steven J, Woodard, Kenton T, Samulski, R Jude
Publicado no Ther Deliv (2010)

Synergistic efficacy of ultrasound, sonosensitizers and chemotherapy: a review

Por Hirschberg, Henry, Madsen, Steen J
Publicado no Ther Deliv (2017)

Review of the Omnipod(®) 5 Automated Glucose Control System Powered by Horizon™ for the treatment of Type 1 diabetes

Por Cobry, Erin C, Berget, Cari, Messer, Laurel H, Forlenza, Gregory P
Publicado no Ther Deliv (2020)

Battling with environments: drug delivery to target tissues with particles and functional biomaterials

Por Yeo, Yoon
Publicado em 2010

Targeted drug delivery across the blood–brain barrier using ultrasound technique

Por Deng, Cheri X
Publicado em 2010

Autoimmune therapies targeting costimulation and emerging trends in multivalent therapeutics

Por Chittasupho, Chuda, Siahaan, Teruna J, Vines, Charlotte M, Berkland, Cory
Publicado em 2011

Phase-shift, stimuli-responsive drug carriers for targeted delivery

Por O’Neill, Brian E, Rapoport, Natalya
Publicado em 2011

Oligonucleotide conjugates for therapeutic applications

Por Winkler, Johannes
Publicado em 2013

Delivery and performance of surfactant replacement therapies to treat pulmonary disorders

Por El-Gendy, Nashwa, Kaviratna, Anubhav, Berkland, Cory, Dhar, Prajnaparamita
Publicado em 2013